Home
ESPR
ESPR News

Latest Esperion Therapeutics Inc. (ESPR) News on July 27, 2024

Esperion to Report Second Quarter 2024 Financial Results on August 12

GlobeNewswire

2 days ago

Esperion to Report Second Quarter 2024 Financial Results on August 12

Esperion to Participate in Upcoming BTIG Biotech Conference

GlobeNewswire

3 days ago

Esperion to Participate in Upcoming BTIG Biotech Conference

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

Zacks

4 days ago

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

New Digital First Marketing Campaign from Esperion Alerts Patients with Uncontrolled LDL Cholesterol to the “Lipid Lurkers” Inside Their Arteries

GlobeNewswire

11 days ago

New Digital First Marketing Campaign from Esperion Alerts Patients with Uncontrolled LDL Cholesterol to the “Lipid Lurkers” Inside Their Arteries

MT Newswires

a month ago

Esperion Therapeutics Enters $304.7 Million Royalty Purchase Agreement with OMERS; Shares Rise

PTC faces another Duchenne drug rejection; Coherus sells Humira biosimilar

BioPharma Dive

a month ago

PTC faces another Duchenne drug rejection; Coherus sells Humira biosimilar

Esperion Announces Monetization of European Royalties and Concurrent Payoff and Termination of Existing Revenue Interest Facility

GlobeNewswire

a month ago

Esperion Announces Monetization of European Royalties and Concurrent Payoff and Termination of Existing Revenue Interest Facility

Strength Seen in Aurinia (AUPH): Can Its 5.6% Jump Turn into More Strength?

Zacks

a month ago

Strength Seen in Aurinia (AUPH): Can Its 5.6% Jump Turn into More Strength?

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers

GOBankingRates

2 months ago

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers

Bumrah delivers as India beat Pakistan in low-scoring thriller

AFP

2 months ago

Bumrah delivers as India beat Pakistan in low-scoring thriller

Italy beat Bosnia in final Euros warm-up

AFP

2 months ago

Italy beat Bosnia in final Euros warm-up

Trump loyalists proud to support 'felon' at Las Vegas rally

AFP

2 months ago

Trump loyalists proud to support 'felon' at Las Vegas rally

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia

Business Insider

2 months ago

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia

The Best Woody Perfume For Women

Insider Monkey

2 months ago

The Best Woody Perfume For Women

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase

Reuters

2 months ago

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase

Insider Monkey

2 months ago

Best Date Night Fragrance in 2024

Why Is Catalyst (CPRX) Up 0.7% Since Last Earnings Report?

Zacks

2 months ago

Why Is Catalyst (CPRX) Up 0.7% Since Last Earnings Report?

Why Is Esperion Therapeutics (ESPR) Up 14.2% Since Last Earnings Report?

Zacks

2 months ago

Why Is Esperion Therapeutics (ESPR) Up 14.2% Since Last Earnings Report?

Esperion's (ESPR) Drugs Get EU Nod for Lowering Heart Risk

Zacks

2 months ago

Esperion's (ESPR) Drugs Get EU Nod for Lowering Heart Risk

Esperion to Participate in Upcoming June Investor Conferences

GlobeNewswire

2 months ago

Esperion to Participate in Upcoming June Investor Conferences

First-In-Class Cholesterol-Lowering Treatment NILEMDO® (NEXLETOL® in the U.S.) and Its Combination with Ezetimibe, NUSTENDI® (NEXLIZET® in the U.S.), Approved In Europe To Treat Hypercholesterolemia and Significantly Reduce Cardiovascular Risk

GlobeNewswire

2 months ago

First-In-Class Cholesterol-Lowering Treatment NILEMDO® (NEXLETOL® in the U.S.) and Its Combination with Ezetimibe, NUSTENDI® (NEXLIZET® in the U.S.), Approved In Europe To Treat Hypercholesterolemia and Significantly Reduce Cardiovascular Risk

MT Newswires

2 months ago

Esperion Therapeutics Says Primary Endpoint Achieved in Hypercholesterolemia Treatment Phase 3 Trial; Shares Rise

Bempedoic Acid Met Primary Endpoint of Phase 3 Trial in Japan for the Treatment for Hypercholesterolemia

GlobeNewswire

2 months ago

Bempedoic Acid Met Primary Endpoint of Phase 3 Trial in Japan for the Treatment for Hypercholesterolemia

Esperion Receives Five Year Patent Extension for Bempedoic Acid, Contained in NEXLETOL® and NEXLIZET®

GlobeNewswire

2 months ago

Esperion Receives Five Year Patent Extension for Bempedoic Acid, Contained in NEXLETOL® and NEXLIZET®

Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

GlobeNewswire

3 months ago

Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Esperion (ESPR) Q1 Earnings Beat, Stock Up on Strong Revenues

Zacks

3 months ago

Esperion (ESPR) Q1 Earnings Beat, Stock Up on Strong Revenues

Esperion Therapeutics, Inc. (NASDAQ:ESPR) Q1 2024 Earnings Call Transcript

Insider Monkey

3 months ago

Esperion Therapeutics, Inc. (NASDAQ:ESPR) Q1 2024 Earnings Call Transcript

GuruFocus.com

3 months ago

Esperion Therapeutics Inc (ESPR) Q1 2024 Earnings Call Transcript Highlights: Soaring Revenues ...

Heart Disease Drugmaker Esperion Therapeutics Reports Highest Revenue Yet, Stock Soars

Benzinga

3 months ago

Heart Disease Drugmaker Esperion Therapeutics Reports Highest Revenue Yet, Stock Soars

GuruFocus.com

3 months ago

Esperion Therapeutics Inc (ESPR) Surpasses Q1 Revenue Forecasts with a 467% Increase

MT Newswires

3 months ago

Top Premarket Gainers

Esperion Therapeutics (ESPR) Q1 Earnings and Revenues Beat Estimates

Zacks

3 months ago

Esperion Therapeutics (ESPR) Q1 Earnings and Revenues Beat Estimates

Associated Press Finance

3 months ago

Esperion Therapeutics: Q1 Earnings Snapshot

Esperion Reports First Quarter 2024 Financial Results

GlobeNewswire

3 months ago

Esperion Reports First Quarter 2024 Financial Results

Esperion to Participate in Upcoming May Investor Conferences

GlobeNewswire

3 months ago

Esperion to Participate in Upcoming May Investor Conferences

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

Zacks

3 months ago

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

Esperion to Report First Quarter 2024 Financial Results on May 7

GlobeNewswire

3 months ago

Esperion to Report First Quarter 2024 Financial Results on May 7

11 Best Low Price Pharma Stocks To Invest In

Insider Monkey

3 months ago

11 Best Low Price Pharma Stocks To Invest In

Esperion Presents Important New Data from CLEAR Outcomes at ACC.24 Highlighting Value of NEXLETOL® (bempedoic acid) Tablets in Diverse Populations Including Women, Hispanics/Latinx and Patients with Obesity

GlobeNewswire

4 months ago

Esperion Presents Important New Data from CLEAR Outcomes at ACC.24 Highlighting Value of NEXLETOL® (bempedoic acid) Tablets in Diverse Populations Including Women, Hispanics/Latinx and Patients with Obesity

Esperion to Ring Nasdaq Opening Bell Today, April 1, 2024

GlobeNewswire

4 months ago

Esperion to Ring Nasdaq Opening Bell Today, April 1, 2024

Why Is Esperion Therapeutics (ESPR) Up 2% Since Last Earnings Report?

Zacks

4 months ago

Why Is Esperion Therapeutics (ESPR) Up 2% Since Last Earnings Report?

Esperion to Participate in 23rd Annual Needham Virtual Healthcare Conference

GlobeNewswire

4 months ago

Esperion to Participate in 23rd Annual Needham Virtual Healthcare Conference

Esperion Announces Data from CLEAR Outcomes Sub-Groups as Poster Presentations, Moderated Session & Industry Expert Theatre to be Presented at ACC.24

GlobeNewswire

4 months ago

Esperion Announces Data from CLEAR Outcomes Sub-Groups as Poster Presentations, Moderated Session & Industry Expert Theatre to be Presented at ACC.24

U.S. FDA Approves Broad New Labels for Esperion’s NEXLETOL® and NEXLIZET® to Prevent Heart Attacks and Cardiovascular Procedures in Both Primary and Secondary Prevention Patients, Regardless of Statin Use

Business Wire

4 months ago

U.S. FDA Approves Broad New Labels for Esperion’s NEXLETOL® and NEXLIZET® to Prevent Heart Attacks and Cardiovascular Procedures in Both Primary and Secondary Prevention Patients, Regardless of Statin Use

U.S. FDA Approves Broad New Labels for NEXLETOL® and NEXLIZET® to Prevent Heart Attacks and Cardiovascular Procedures in Both Primary and Secondary Prevention Patients, Regardless of Statin Use

GlobeNewswire

4 months ago

U.S. FDA Approves Broad New Labels for NEXLETOL® and NEXLIZET® to Prevent Heart Attacks and Cardiovascular Procedures in Both Primary and Secondary Prevention Patients, Regardless of Statin Use

CHMP Issues Positive Opinions For Both Bempedoic Acid And The Bempedoic Acid / Ezetimibe Fixed-Dose Combination Tablet As Treatments For Hypercholesterolemia And Significantly Reducing Cardiovascular Events

GlobeNewswire

4 months ago

CHMP Issues Positive Opinions For Both Bempedoic Acid And The Bempedoic Acid / Ezetimibe Fixed-Dose Combination Tablet As Treatments For Hypercholesterolemia And Significantly Reducing Cardiovascular Events

11 Best Small Cap Pharma Stocks to Invest In

Insider Monkey

5 months ago

11 Best Small Cap Pharma Stocks to Invest In

Zacks Industry Outlook Highlights United Therapeutics, Esperion Therapeutics., Heron Therapeutics, Lyra Therapeutics and Aldeyra Therapeutics

Zacks

5 months ago

Zacks Industry Outlook Highlights United Therapeutics, Esperion Therapeutics., Heron Therapeutics, Lyra Therapeutics and Aldeyra Therapeutics

5 Small Drug Stocks to Buy From a Rebounding Industry

Zacks

5 months ago

5 Small Drug Stocks to Buy From a Rebounding Industry

Esperion Therapeutics, Inc. (NASDAQ:ESPR) Q4 2023 Earnings Call Transcript

Insider Monkey

5 months ago

Esperion Therapeutics, Inc. (NASDAQ:ESPR) Q4 2023 Earnings Call Transcript

Esperion (ESPR) Q4 Earnings Top, Stock Up on Strong Revenues

Zacks

5 months ago

Esperion (ESPR) Q4 Earnings Top, Stock Up on Strong Revenues

Thomson Reuters StreetEvents

5 months ago

Q4 2023 Esperion Therapeutics Inc Earnings Call

Esperion Therapeutics Inc (ESPR) Reports Strong Revenue Growth in Q4 and FY 2023

GuruFocus.com

5 months ago

Esperion Therapeutics Inc (ESPR) Reports Strong Revenue Growth in Q4 and FY 2023

Esperion Therapeutics (ESPR) Reports Q4 Loss, Tops Revenue Estimates

Zacks

5 months ago

Esperion Therapeutics (ESPR) Reports Q4 Loss, Tops Revenue Estimates

Associated Press Finance

5 months ago

Esperion Therapeutics: Q4 Earnings Snapshot

Esperion Reports Fourth Quarter and Full Year 2023 Financial Results

GlobeNewswire

5 months ago

Esperion Reports Fourth Quarter and Full Year 2023 Financial Results

12 Best Medical Stocks to Buy Under $10

Insider Monkey

5 months ago

12 Best Medical Stocks to Buy Under $10

Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

GlobeNewswire

5 months ago

Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Should You Sell Esperion Therapeutics (ESPR)?

Insider Monkey

5 months ago

Should You Sell Esperion Therapeutics (ESPR)?

Esperion Therapeutics (ESPR) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Zacks

5 months ago

Esperion Therapeutics (ESPR) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Esperion to Report Fourth Quarter and Full Year 2023 Financial Results on February 27

GlobeNewswire

5 months ago

Esperion to Report Fourth Quarter and Full Year 2023 Financial Results on February 27

Seadrill (SDRL) Secures New Contracts Worth $97.5 Million

Zacks

6 months ago

Seadrill (SDRL) Secures New Contracts Worth $97.5 Million

Business Wire

6 months ago

Distribution Dates and Amounts Announced for Eaton Vance Closed-End Funds

RFK, Esperion Therapeutics Announce 2024 Promotional Schedule

GlobeNewswire

6 months ago

RFK, Esperion Therapeutics Announce 2024 Promotional Schedule

Trinity Capital Receives Investment Grade Rating from Morningstar DBRS

PR Newswire

6 months ago

Trinity Capital Receives Investment Grade Rating from Morningstar DBRS

Whether or not the Fed cuts rates is not the right question

Yahoo Finance

6 months ago

Whether or not the Fed cuts rates is not the right question

Bitcoin ETFs Are Here. Why You Should Buy and Hold Long Term

Motley Fool

6 months ago

Bitcoin ETFs Are Here. Why You Should Buy and Hold Long Term

Byline Bancorp, Inc. (NYSE:BY) Q4 2023 Earnings Call Transcript

Insider Monkey

6 months ago

Byline Bancorp, Inc. (NYSE:BY) Q4 2023 Earnings Call Transcript

Q3 Earnings Outperformers: Torrid (NYSE:CURV) And The Rest Of The Apparel Retailer Stocks

StockStory

6 months ago

Q3 Earnings Outperformers: Torrid (NYSE:CURV) And The Rest Of The Apparel Retailer Stocks

Thomson Reuters StreetEvents

6 months ago

Q4 2023 Old National Bancorp Earnings Call

Associated Press Finance

6 months ago

Hanmi Financial: Q4 Earnings Snapshot

Esperion Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters’ Option to Purchase Additional Shares

GlobeNewswire

6 months ago

Esperion Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters’ Option to Purchase Additional Shares

QCR Holdings (QCRH) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures

Zacks

6 months ago

QCR Holdings (QCRH) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures

Consensus Cloud Solutions to Host Q4 and 2023 Year End Investor Call on February 21, 2024

Business Wire

6 months ago

Consensus Cloud Solutions to Host Q4 and 2023 Year End Investor Call on February 21, 2024

Shareholders in Southside Bancshares (NASDAQ:SBSI) are in the red if they invested a year ago

Simply Wall St.

6 months ago

Shareholders in Southside Bancshares (NASDAQ:SBSI) are in the red if they invested a year ago

Bear of the Day: Nabors Industries (NBR)

Zacks

6 months ago

Bear of the Day: Nabors Industries (NBR)

Zacks Value Investor Highlights: Potbelly, Xperi, Virco, Enviri and Anywhere Real Estate

Zacks

6 months ago

Zacks Value Investor Highlights: Potbelly, Xperi, Virco, Enviri and Anywhere Real Estate

5 Outstanding Small Cap Value Stocks

Zacks

6 months ago

5 Outstanding Small Cap Value Stocks

Bull Of The Day: Navigator Holdings (NVGS)

Zacks

6 months ago

Bull Of The Day: Navigator Holdings (NVGS)

Analysts Expect Breakeven For Theravance Biopharma, Inc. (NASDAQ:TBPH) Before Long

Simply Wall St.

6 months ago

Analysts Expect Breakeven For Theravance Biopharma, Inc. (NASDAQ:TBPH) Before Long

Esperion Announces Pricing of $85.1 Million Public Offering of Common Stock

GlobeNewswire

6 months ago

Esperion Announces Pricing of $85.1 Million Public Offering of Common Stock

GlobeNewswire

6 months ago

Titan Machinery Elects New Board Member

Esperion Announces Proposed Public Offering of Common Stock

GlobeNewswire

6 months ago

Esperion Announces Proposed Public Offering of Common Stock

Old National, NCRC Announce Addendum to Increase Community Growth Plan to $9.5 Billion

GlobeNewswire

6 months ago

Old National, NCRC Announce Addendum to Increase Community Growth Plan to $9.5 Billion

Redfin Report: Housing-Market Activity Is Picking Up in 2024, But Severe Winter Weather Keeps Some Buyers and Sellers on the Sidelines

Business Wire

6 months ago

Redfin Report: Housing-Market Activity Is Picking Up in 2024, But Severe Winter Weather Keeps Some Buyers and Sellers on the Sidelines

ACNB (ACNB) Surges 6.5%: Is This an Indication of Further Gains?

Zacks

6 months ago

ACNB (ACNB) Surges 6.5%: Is This an Indication of Further Gains?

BigCommerce Wins Vendors in Partnership Award for Best Commerce or Multi-Vendor Platform

Business Wire

6 months ago

BigCommerce Wins Vendors in Partnership Award for Best Commerce or Multi-Vendor Platform

More than half of Gen Z and Millennial Grocery Shoppers Prefer Self-Checkout, According to New Consumer Survey from NCR Voyix

Business Wire

6 months ago

More than half of Gen Z and Millennial Grocery Shoppers Prefer Self-Checkout, According to New Consumer Survey from NCR Voyix

Titan Machinery (TITN) Buys Scott Supply to Expand Footprint

Zacks

6 months ago

Titan Machinery (TITN) Buys Scott Supply to Expand Footprint

Fraud, Data Breaches and Password Crisis Drive CompoSecure’s Vision for the Future of Payment Security: CEO Predicts Next Generation of Payment Cards in 2024

GlobeNewswire

7 months ago

Fraud, Data Breaches and Password Crisis Drive CompoSecure’s Vision for the Future of Payment Security: CEO Predicts Next Generation of Payment Cards in 2024

NeuroPace Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2023 and Provides Business Updates

GlobeNewswire

7 months ago

NeuroPace Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2023 and Provides Business Updates

NuScale Power Positions Company for Next Phase of Growth

Business Wire

7 months ago

NuScale Power Positions Company for Next Phase of Growth

Investing in CapStar Financial Holdings (NASDAQ:CSTR) five years ago would have delivered you a 33% gain

Simply Wall St.

7 months ago

Investing in CapStar Financial Holdings (NASDAQ:CSTR) five years ago would have delivered you a 33% gain

ELECTRIC UTILITY INDUSTRY LEADER TOM KUHN JOINS ANTERIX BOARD OF DIRECTORS AS VICE CHAIRMAN

PR Newswire

7 months ago

ELECTRIC UTILITY INDUSTRY LEADER TOM KUHN JOINS ANTERIX BOARD OF DIRECTORS AS VICE CHAIRMAN

Liquidity Services Acquires Sierra Auction, a Leading Auctioneer of Vehicles, Equipment, and Surplus Assets for Government and Commercial Organizations

GlobeNewswire

7 months ago

Liquidity Services Acquires Sierra Auction, a Leading Auctioneer of Vehicles, Equipment, and Surplus Assets for Government and Commercial Organizations

Esperion and Daiichi Sankyo Europe Announce $125 Million Amendment to Their Collaboration, Including Resolution of Pending Litigation

Business Wire

7 months ago

Esperion and Daiichi Sankyo Europe Announce $125 Million Amendment to Their Collaboration, Including Resolution of Pending Litigation

ORIC Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference

GlobeNewswire

7 months ago

ORIC Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference

SeaDrill Stock Tops Benchmark; Profit Jumped 82% in 14 Months

Investor's Business Daily

7 months ago

SeaDrill Stock Tops Benchmark; Profit Jumped 82% in 14 Months

Returns At WNS (Holdings) (NYSE:WNS) Appear To Be Weighed Down

Simply Wall St.

7 months ago

Returns At WNS (Holdings) (NYSE:WNS) Appear To Be Weighed Down

Statement from the Board of Directors of Procaps Group

Business Wire

7 months ago

Statement from the Board of Directors of Procaps Group

Share on Social Networks: